Rudin, Charles M.
Poirier, John T.
Article History
First Online: 13 December 2016
Competing interests
: C.M.R. has been a paid consultant regarding oncology drug development for BMS, Celgene, Chugai, Harpoon, and Novartis. J.T.P. declares no competing interests.